Call +1 (833) 552-7181 or Contact us Earn $25 in coupons on your first order with Aladdin!
Toggle Nav
My Cart
Search
Advanced Search
Menu
Sign In
྾

Activity of human CYP2C9 assessed as compound formation treated with 2 and 20 uM brivanib for 20 mins by LC/MS analysis in presence of NADPH

Basic Information

ID: ALA3531852

Type: ADME

Description: Activity of human CYP2C9 assessed as compound formation treated with 2 and 20 uM brivanib for 20 mins by LC/MS analysis in presence of NADPH

Format: BAO_0000357

Organism: Homo sapiens

Target:  Cytochrome P450 2C9(ALA3397)

Document:  ALA3526086

Activity of human CYP2C9 assessed as compound formation treated with 2 and 20 uM brivanib for 20 mins by LC/MS analysis in presence of NADPH: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA3531852

Drug metabolism

Total(1)

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
386.382.702.70
Privacy Policy Website Terms of Use Return policy Terms and Conditions of Sale Cookie Policy Sales Policy
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Copyright © 2023-present Aladdin Scientific Corp . All rights reserved.